Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes
In this study, we describe one of the longest follow-up periods for patients with diabetes and 3-vessel coronary artery disease who underwent CABG or PCI and confirmed that the shorter-term benefits seen in randomized trials do translate into longer-term reductions in risk of death, myocardial infarction, or repeat revascularization.
Authors
- Jimmy J.H. Kang (ORCID: https://orcid.org/0000-0002-3351-2593)
- Ryaan EL‐Andari (ORCID: https://orcid.org/0000-0001-7146-4337)
- Padma Kaul (ORCID: https://orcid.org/0000-0003-2239-3944)
- Jeevan Nagendran (ORCID: https://orcid.org/0000-0002-2050-6717)
- Finlay A. McAlister (ORCID: https://orcid.org/0000-0001-7435-3341)
- Nicholas M. Fialka (ORCID: https://orcid.org/0000-0002-7277-6188)
- Jayan Nagendran (ORCID: https://orcid.org/0000-0001-5827-9823)
- William Kent (ORCID: https://orcid.org/0000-0002-3808-0777)
- Yongzhe Hong (ORCID: https://orcid.org/0000-0003-0232-2014)
Institutions
- University of Alberta (CA)
- University of Calgary (CA)
- Libin Cardiovascular Institute of Alberta (CA)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1161/jaha.124.039663
- Citations
- 2
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 4.01